Patents by Inventor Miyoung OH

Miyoung OH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12044465
    Abstract: A method for controlling and managing a front door refrigerator using an application installed in a recording medium, according to an embodiment of the present invention, comprises: a step in which a user logs into a front door refrigerator control application installed in a recording medium including a mobile device, thereby allowing a main screen including menu display regions to be displayed on a display unit of the mobile device; and a step in which a storage information confirmation menu is selected from among a plurality of execution menus displayed in the menu display regions, wherein, when the storage information confirmation menu is selected, storage information of a product stored in the front door refrigerator is output to the display unit of the mobile device.
    Type: Grant
    Filed: February 13, 2020
    Date of Patent: July 23, 2024
    Assignee: LG ELECTRONICS INC.
    Inventors: Seojin Lee, Wonjin Lee, Insun Yeo, Eugene Myung, Miyoung Seo, Kyukwan Choi, Minkyu Oh, Yezo Yun
  • Patent number: 11332528
    Abstract: The present invention provides anti-CEACAM1 antibodies with improved binding abilities specific to CEACAM1, and a use thereof. Anti-CEACAM1 antibodies according to the present invention exhibit superior binding abilities specific to CEACAM1, and also activate the anti-cancer immune functions of cytotoxic T cells and natural killer cells, and thus, each one of them can be effectively used as an anti-cancer agent and a composition for treating cancer.
    Type: Grant
    Filed: March 23, 2018
    Date of Patent: May 17, 2022
    Assignees: MOGAM INSTITUTE FOR BIOMEDICAL RESEARCH, GREEN CROSS CORPORATION
    Inventors: So-Young Eun, Miyoung Oh, Hye-Young Park, Mijung Lee, Aerin Yoon, Hye In Yum, Hyemi Nam, Eunhee Lee, Jongwha Won
  • Patent number: 10851175
    Abstract: The present invention relates to an antibody specifically bound to mesothelin (MSLN), a nucleic acid encoding the antibody, a vector and a host cell including the nucleic acid, a method for producing the antibody, and a pharmaceutical composition for treating cancer or tumor including the antibody as an active ingredient. The antibody specifically bound to the mesothelin according to the present invention has high affinity and specificity to an antigen, such that it is possible to develop an antibody effectively usable for treatment or diagnosis of cancer or tumor diseases.
    Type: Grant
    Filed: September 23, 2016
    Date of Patent: December 1, 2020
    Assignees: MOGAM INSTITUTE FOR BIOMEDICAL RESEARCH, GREEN CROSS CORPORATION
    Inventors: Dong-Sik Kim, Eun Jung Song, Mijung Lee, Eun-Hee Lee, Miyoung Oh, Jae Chan Park, Kisu Kim, Sujeong Kim, Hyung-Kwon Lim, Kyuhyun Lee, Jongwha Won, Soongyu Choi, Young Seoub Park
  • Publication number: 20200109196
    Abstract: The present invention provides anti-CEACAM1 antibodies with improved binding abilities specific to CEACAM1, and a use thereof. Anti-CEACAM1 antibodies according to the present invention exhibit superior binding abilities specific to CEACAM1, and also activate the anti-cancer immune functions of cytotoxic T cells and natural killer cells, and thus, each one of them can be effectively used as an anti-cancer agent and a composition for treating cancer.
    Type: Application
    Filed: March 23, 2018
    Publication date: April 9, 2020
    Applicants: MOGAM INSTITUTE FOR BIOMEDICAL RESEARCH, GREEN CROSS CORPORATION
    Inventors: So-Young EUN, Miyoung OH, Hye-Young PARK, Mijung LEE, Aerin YOON, Hye In YUM, Hyemi NAM, Eunhee LEE, Jongwha WON
  • Publication number: 20180346588
    Abstract: The present invention relates to an antibody specifically bound to mesothelin (MSLN), a nucleic acid encoding the antibody, a vector and a host cell including the nucleic acid, a method for producing the antibody, and a pharmaceutical composition for treating cancer or tumor including the antibody as an active ingredient. The antibody specifically bound to the mesothelin according to the present invention has high affinity and specificity to an antigen, such that it is possible to develop an antibody effectively usable for treatment or diagnosis of cancer or tumor diseases.
    Type: Application
    Filed: September 23, 2016
    Publication date: December 6, 2018
    Applicants: MOGAM INSTITUTE FOR BIOMEDICAL RESEARCH, GREEN CROSS CORPORATION
    Inventors: Dong-Sik KIM, Eun Jung SONG, Mijung LEE, Eun-Hee LEE, Miyoung OH, Jae Chan PARK, Kisu KIM, Sujeong KIM, Hyung-Kwon LIM, Kyuhyun LEE, Jongwha WON, Soongyu CHOI, Young Seoub PARK